United Therapeutics Corporation UTHR Cash Flow

United therapeutics corporation (UTHR)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities:
Net income (loss)
137,700	52,600	132,400	205,100	-494,600	65,300	106,500	172,900	244,500	19,000	276,300	-56,000	178,600	110,300	161,800	206,100	235,500	104,600	464,400	99,200	-16,600	115,961	-25,237	111,852	137,524	-30,314	62,685	79,864	62,325	83,255	78,111	72,316	70,760	43,189	84,398	73,891	16,390	9,544	39,736	37,707	18,929
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
12,400	12,500	12,700	10,400	10,300	10,500	9,400	8,100	7,900	7,700	7,700	7,700	7,900	7,800	8,200	7,900	7,700	7,900	8,300	8,400	8,300	8,887	8,107	7,641	7,565	7,753	7,661	7,680	8,165	7,290	6,915	6,292	6,648	4,898	4,991	4,837	5,809	3,739	5,028	4,583	4,570
Share-based compensation expense
30,800	29,500	23,900	-37,200	29,200	2,800	51,400	20,500	-101,100	118,500	-24,000	-1,900	-19,100	105,300	49,900	1,500	-144,600	117,400	-118,900	47,300	234,500	-	-	-	-60,723	178,202	74,385	32,986	35,213	-10,453	31,145	9,447	-24	22,075	-47,609	-27,037	36,856	52,815	31,372	-370	30,125
Impairments of investments in privately-held companies
5,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity loss in affiliate and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-604	1,942	-1,886
Excess tax benefits from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	1,300	1,100	1,400	2,100	6,000	7,900	14,800	8,700	7,617	9,143	8,434	5,606	3,492	3,173	1,672	962	970	1,400	366	318	4,861	197	2,313	3,976	5,100	2,371	5,596	10,759
Other
22,800	1,800	-9,100	43,700	-6,700	2,600	-6,500	2,000	100	10,200	-700	1,400	8,500	-7,000	-1,000	-2,600	1,100	-1,600	-10,400	2,700	1,800	-22,722	-439	-381	-658	-2,074	205	-1,002	-311	-5,648	-610	-8,187	-26	-500	5,829	-1,176	-6,767	-	-	-	-
Provision for inventory obsolescence
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	330	-188	-	-235	1,343	347	2,276	58	1,581	1,265	554	1,016	712	116
Current and deferred income tax expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38,494	38,655	28,510	41,697	30,382	30,974	33,176	16,048	19,225	35,723	10,436	-5,039	17,998	19,212	9,752
Amortization of debt discount and debt issue costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,100	2,000	-	3,436	3,267	3,265	3,189	3,172	3,157	3,083	2,162	2,997	2,981	2,924	5,712	4,627	4,549	4,471	4,319	4,247	4,172	4,101
Amortization of discount or premium on investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-400	-1,000	-	-1,207	-1,384	-1,604	-1,435	-1,028	-1,032	-1,006	-1,301	-970	-1,199	-1,134	-1,068	-969	-1,272	-1,165	-1,109	-589	-498	-378
Changes in operating assets and liabilities:
Accounts receivable
-1,700	-32,200	2,500	21,300	-16,000	-39,500	-36,100	40,200	-86,000	45,400	-22,100	85,900	-26,500	-10,000	-13,600	43,300	2,000	13,100	10,500	13,000	-6,100	22,376	-73,149	80,560	5,913	-5,217	-211	30,485	-15,030	4,475	10,728	8,851	-63	1,507	5,165	17,414	-7,928	-1,861	-7,656	23,657	9,312
Inventories
-6,100	-2,400	-6,100	-2,700	-1,700	-5,100	4,700	-2,500	-6,400	-16,500	2,200	7,500	7,300	11,600	4,100	3,300	5,500	-1,000	5,900	500	1,400	4,130	5,604	6,467	4,799	760	3,929	5,146	2,559	1,143	3,322	2,043	-575	2,059	7,249	4,770	1,977	1,445	2,994	5,053	-296
Accounts payable and accrued expenses
-18,800	-11,400	-1,900	24,700	-27,700	-32,900	-18,000	17,900	22,000	28,300	17,100	21,900	-1,100	-13,300	-5,900	19,300	500	-8,800	2,500	18,600	4,700	-42,655	15,838	8,293	11,724	-5,126	5,870	10,678	-3,915	-	-	-	-	-	-	-	-	-	-	-	-
Other assets and liabilities
-61,900	11,500	4,800	16,600	169,000	43,400	-37,900	-100	-10,100	9,300	43,200	62,700	-53,800	50,800	-5,300	63,700	-37,400	179,100	-221,300	105,000	119,000	-1,647	73,981	89,964	-25,298	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,961	5,254	-	-426	-1,763	4,101	1,094	-1,650	686	457
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-469	-923	-3,162	3,320	4,795	-52	1,642	5,011	-4,974	1,426	4,270	1,805	2,490	-1,555	2,036
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	422	-38,971	-	149	7,041	-6,150	4,717	1,878	2,300	-11,629
Accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,629	915	-	-38,194	8,749	1,409	10,285	3,642	8,771	2,914
Other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-47,226	-55,156	-51,483	-36,448	-37,302	-39,235	-32,774	-75,575	23,772	-23,085	-18,671	-43,315	-4,733	-6,973	-4,655
Net cash provided by (used in) operating activities
214,600	102,500	185,400	132,900	-627,400	85,400	237,500	179,800	275,700	-85,800	258,500	70,700	230,800	163,400	228,700	125,700	125,800	25,500	207,200	41,000	109,100	90,646	208,537	-54,480	110,597	104,421	139,300	83,848	97,698	105,209	93,448	87,386	37,585	51,629	80,678	64,537	53,351	39,252	102,828	35,233	34,219
Cash flows from investing activities:
Purchases of property, plant and equipment
13,000	24,700	13,600	20,300	25,100	51,800	41,500	53,500	37,600	27,800	22,000	20,900	15,600	14,700	9,100	10,400	3,800	31,500	10,500	3,800	4,000	2,243	13,645	12,836	18,676	13,413	9,417	4,837	4,243	21,255	6,730	43,638	40,282	-747	17,842	12,547	6,336	5,441	4,082	2,755	6,362
Purchases of held-to-maturity and other investments
-	-	-	-	-	35,900	25,700	10,800	26,900	0	26,700	0	25,100	-	-	-	-	0	1,500	37,000	24,300	3,530	5,075	25	110,070	323,565	276,172	50,716	111,745	231,315	56,584	107,994	183,423	199,113	249,595	193,727	173,249	203,699	315,930	70,820	71,776
Sales/maturities of held-to-maturity investments
-	0	1,500	800	37,400	35,600	25,400	800	26,800	300	26,500	5,300	20,800	51,600	29,200	28,600	21,000	88,000	59,600	76,100	96,700	57,767	116,669	140,039	235,125	180,625	109,764	112,888	126,623	87,871	110,928	151,345	177,714	214,542	213,022	162,062	144,250	111,180	113,500	105,549	91,299
Purchases of available-for-sale investments
479,200	296,800	455,700	139,500	379,500	144,200	180,000	352,500	86,000	265,800	156,100	150,800	145,700	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales/maturities of available-for-sale investments
451,400	361,600	188,200	116,400	313,900	137,100	49,000	56,200	70,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible assets acquired, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	5,200	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales of investments in equity securities
13,200	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of investments in privately-held companies
-	0	1,000	0	7,000	0	0	0	5,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restrictions on cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-34,648	3,591	12,222	4,934
Net cash used in investing activities
-27,600	66,200	-298,700	-42,600	-60,300	-72,200	-329,900	-359,800	-58,700	-278,400	-200,200	-191,400	-165,600	8,500	20,100	7,700	12,000	56,500	347,600	31,100	68,400	51,994	97,949	82,178	106,379	-156,353	-175,825	26,569	10,635	-164,699	47,614	-287	-45,991	16,176	-57,962	-44,212	-35,335	-63,312	-191,078	36,927	8,227
Cash flows from financing activities:
Proceeds from line of credit
-	0	0	0	800,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of line of credit
50,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of debt issuance costs
-	-	-	-	-	0	0	12,500	700	0	0	0	700	0	0	0	6,800	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments to repurchase common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	104,500	135,800	136,500	123,200	0	57,700	184,500	152,300	79,942	25,596	279,929	97,633	1	0	36,534	5,904	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of stock options
700	0	0	1,100	8,800	100	600	5,700	9,200	1,700	1,600	3,600	33,000	1,500	1,200	2,400	2,600	6,300	8,600	14,300	10,100	10,809	17,220	13,795	8,376	6,715	9,799	5,839	4,258	7,116	6,575	1,304	1,810	450	224	9,748	13,976	21,002	9,825	18,273	36,327
Proceeds from the issuance of stock under employee stock purchase plan
2,500	0	1,900	0	2,200	0	1,800	0	2,100	100	1,900	0	2,100	0	2,100	0	2,200	0	2,100	0	1,900	-29	1,657	-62	1,734	0	1,416	-60	1,378	-	-	-	-	-	-	-	-	-	-	-	-
Restricted stock units withheld for taxes
3,400	0	200	0	1,900	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefits from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	1,300	1,100	1,400	2,100	6,000	7,900	14,800	8,700	7,617	9,143	8,434	5,606	3,492	3,173	1,672	962	970	1,400	366	318	4,861	197	2,313	3,976	5,100	2,371	5,596	10,759
Principal payments of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	900	7,800	100	-	2,800	90,300	14,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-50,200	-150,000	-48,300	400	809,100	100	2,400	-6,800	10,600	1,800	3,500	3,600	34,400	-101,700	-132,300	-140,500	-123,200	-13,800	-41,900	-245,700	-145,600	-239,345	-72,576	-182,762	-81,917	8,886	14,388	-29,083	694	-49,988	-34,950	-86,330	2,128	-248,513	421	12,061	17,952	63,605	12,196	23,869	47,086
Effect of exchange rate changes on cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-200	-1,000	-2,200	400	-1,600	-2,100	1,500	-3,100	-2,928	-1,034	316	-154	-295	817	90	-931	83	300	-422	268	-600	-274	-228	833	2,431	831	-576	72
Net increase in cash and cash equivalents
136,800	18,700	-161,600	90,700	121,400	13,200	-89,900	-186,800	227,600	-362,400	61,600	-116,700	99,600	70,000	115,500	-9,300	15,000	66,600	510,800	-172,100	28,800	-99,633	232,876	-154,748	134,905	-43,341	-21,320	81,424	108,096	-109,395	106,412	347	-6,010	-181,308	22,863	32,158	36,801	41,976	-75,223	95,453	89,604
Supplemental cash flow information:
Cash paid for interest
7,500	9,300	11,100	11,400	9,200	2,500	2,400	2,200	2,300	3,700	2,200	600	1,000	1,400	0	0	100	0	300	0	700	757	2,016	756	1,971	736	2,007	744	2,031	739	2,005	755	1,803	1,337	706	1,327	733	-	-	-	-
Cash (received) paid for income taxes
-8,700	25,800	31,700	61,800	900	50,600	20,600	31,300	200	-	-	-	-	78,700	61,700	133,400	88,600	176,400	6,800	93,900	16,200	17,917	37,317	73,563	66,803	22,508	33,983	40,700	44,949	26,459	18,737	27,633	28,676	21,460	10,994	8,863	5,193	20,348	156	1,303	876
Non-cash investing and financing activities:
Non-cash additions to property, plant and equipment
5,400	50,600	-100	-1,800	5,800	-6,700	800	3,500	13,900	3,800	700	500	6,500	-300	-200	100	3,300	-1,300	1,000	1,000	400	-98	-1,131	-2,478	6,907	5,964	369	1,886	799	-2,955	-1,129	-3,179	9,083	8,773	7,295	4,663	2,332	-	-	-	-
Issuance of common stock upon conversion of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	0	1,400	6,000	100	51,200	7,300	235,500	27,800	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-